◄ back to all posts
Financial data and stock pages provided by
Fintel.io
JNJ: Johnson & Johnson Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 390,358.96 |
| Enterprise Value ($M) | 403,100.73 |
| Book Value ($M) | 58,955.00 |
| Book Value / Share | 22.40 |
| Price / Book | 6.62 |
| NCAV ($M) | -49,085.00 |
| NCAV / Share | -18.65 |
| Price / NCAV | -7.95 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.17 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.13 |
| Current Ratio | 1.44 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 41,987.00 |
| Assets | 150,027.00 |
| Liabilities | 91,072.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | n/a |
| Net Income | 15,297.00 |
| Earnings Per Share Diluted | 5.61 |
| Earnings Per Share Basic | 5.70 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 22,201.00 |
| Cash from Investing | -3,167.00 |
| Cash from Financing | -3,167.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 5.70 | -2.82 | |
| 13G/A | BlackRock Inc. | 6.90 | 9.69 | |
| 13G/A | Vanguard Group Inc | 8.25 | 8.24 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| JNJ / Johnson & Johnson 10-Q – Quarterly Report – 10-Q | ||
| JNJ / Johnson & Johnson 10-Q – Quarterly Report – 10-Q | ||
| JNJ / Johnson & Johnson 10-Q Quarterly Report 1Q 10-Q 2019 | ||
| JNJ / Johnson & Johnson 10-K 2018 (Annual Report) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 435,744 | 9,051,900 | 4.81 | |
| 787,011 | 8,671,900 | 9.08 | |
| 984,735 | 10,305,300 | 9.56 | |
| 596,908 | 9,543,900 | 6.25 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CTLT – Catalent Inc. | EBS – Emergent Biosolutions, Inc. |
| HSP – Hospira | LCI – Lannett Co., Inc. |
| LLY – Eli Lilly & Co. |
Financial data and stock pages provided by
Fintel.io
